nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—ABCB1—Levothyroxine—hypothyroidism	0.114	0.336	CbGbCtD
Maprotiline—ABCB1—Liothyronine—hypothyroidism	0.114	0.336	CbGbCtD
Maprotiline—ABCB1—Liotrix—hypothyroidism	0.111	0.328	CbGbCtD
Maprotiline—Abdominal cramps—Dextrothyroxine—hypothyroidism	0.0114	0.0258	CcSEcCtD
Maprotiline—Abdominal cramps—Levothyroxine—hypothyroidism	0.0114	0.0258	CcSEcCtD
Maprotiline—HTR2A—cerebellar cortex—hypothyroidism	0.011	0.077	CbGeAlD
Maprotiline—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00862	0.0195	CcSEcCtD
Maprotiline—Myocardial infarction—Liothyronine—hypothyroidism	0.00857	0.0194	CcSEcCtD
Maprotiline—Abdominal cramps—Liotrix—hypothyroidism	0.00836	0.019	CcSEcCtD
Maprotiline—SLC6A3—nerve—hypothyroidism	0.00833	0.0582	CbGeAlD
Maprotiline—CYP1A2—urine—hypothyroidism	0.00749	0.0523	CbGeAlD
Maprotiline—Tingling sensation—Liotrix—hypothyroidism	0.00702	0.0159	CcSEcCtD
Maprotiline—Arrhythmia—Liothyronine—hypothyroidism	0.00701	0.0159	CcSEcCtD
Maprotiline—SLC6A2—nerve—hypothyroidism	0.00672	0.0469	CbGeAlD
Maprotiline—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.00669	0.0152	CcSEcCtD
Maprotiline—Hyperkinesia—Levothyroxine—hypothyroidism	0.00669	0.0152	CcSEcCtD
Maprotiline—HTR7—nerve—hypothyroidism	0.00648	0.0452	CbGeAlD
Maprotiline—Disorientation—Dextrothyroxine—hypothyroidism	0.00623	0.0141	CcSEcCtD
Maprotiline—Disorientation—Levothyroxine—hypothyroidism	0.00623	0.0141	CcSEcCtD
Maprotiline—DRD2—nerve—hypothyroidism	0.00613	0.0428	CbGeAlD
Maprotiline—Increased appetite—Levothyroxine—hypothyroidism	0.00593	0.0134	CcSEcCtD
Maprotiline—Increased appetite—Dextrothyroxine—hypothyroidism	0.00593	0.0134	CcSEcCtD
Maprotiline—Hypertension—Liothyronine—hypothyroidism	0.0059	0.0134	CcSEcCtD
Maprotiline—HTR2A—urine—hypothyroidism	0.00586	0.0409	CbGeAlD
Maprotiline—Tachycardia—Liothyronine—hypothyroidism	0.00544	0.0123	CcSEcCtD
Maprotiline—CYP2D6—urine—hypothyroidism	0.00533	0.0373	CbGeAlD
Maprotiline—Hypotension—Liothyronine—hypothyroidism	0.00521	0.0118	CcSEcCtD
Maprotiline—Hyperkinesia—Liotrix—hypothyroidism	0.00492	0.0112	CcSEcCtD
Maprotiline—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00491	0.0111	CcSEcCtD
Maprotiline—Muscular weakness—Levothyroxine—hypothyroidism	0.00491	0.0111	CcSEcCtD
Maprotiline—Dysphagia—Levothyroxine—hypothyroidism	0.00482	0.0109	CcSEcCtD
Maprotiline—Dysphagia—Dextrothyroxine—hypothyroidism	0.00482	0.0109	CcSEcCtD
Maprotiline—Sweating increased—Dextrothyroxine—hypothyroidism	0.00469	0.0106	CcSEcCtD
Maprotiline—Sweating increased—Levothyroxine—hypothyroidism	0.00469	0.0106	CcSEcCtD
Maprotiline—Disorientation—Liotrix—hypothyroidism	0.00458	0.0104	CcSEcCtD
Maprotiline—Body temperature increased—Liothyronine—hypothyroidism	0.00441	0.00999	CcSEcCtD
Maprotiline—Increased appetite—Liotrix—hypothyroidism	0.00436	0.00989	CcSEcCtD
Maprotiline—Weight decreased—Levothyroxine—hypothyroidism	0.00436	0.00988	CcSEcCtD
Maprotiline—Weight decreased—Dextrothyroxine—hypothyroidism	0.00436	0.00988	CcSEcCtD
Maprotiline—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00423	0.0096	CcSEcCtD
Maprotiline—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00423	0.0096	CcSEcCtD
Maprotiline—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00421	0.00954	CcSEcCtD
Maprotiline—Myocardial infarction—Levothyroxine—hypothyroidism	0.00421	0.00954	CcSEcCtD
Maprotiline—Cerebrovascular accident—Liotrix—hypothyroidism	0.00418	0.00948	CcSEcCtD
Maprotiline—HTR2A—nerve—hypothyroidism	0.00404	0.0282	CbGeAlD
Maprotiline—Muscular weakness—Liotrix—hypothyroidism	0.00361	0.00819	CcSEcCtD
Maprotiline—Flushing—Dextrothyroxine—hypothyroidism	0.00358	0.00811	CcSEcCtD
Maprotiline—Flushing—Levothyroxine—hypothyroidism	0.00358	0.00811	CcSEcCtD
Maprotiline—CHRM4—testis—hypothyroidism	0.00357	0.0249	CbGeAlD
Maprotiline—Dysphagia—Liotrix—hypothyroidism	0.00354	0.00803	CcSEcCtD
Maprotiline—Bronchospasm—Liotrix—hypothyroidism	0.00348	0.0079	CcSEcCtD
Maprotiline—Sweating increased—Liotrix—hypothyroidism	0.00345	0.00782	CcSEcCtD
Maprotiline—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00344	0.00781	CcSEcCtD
Maprotiline—Arrhythmia—Levothyroxine—hypothyroidism	0.00344	0.00781	CcSEcCtD
Maprotiline—Alopecia—Dextrothyroxine—hypothyroidism	0.00341	0.00772	CcSEcCtD
Maprotiline—Alopecia—Levothyroxine—hypothyroidism	0.00341	0.00772	CcSEcCtD
Maprotiline—Tension—Dextrothyroxine—hypothyroidism	0.00329	0.00746	CcSEcCtD
Maprotiline—Tension—Levothyroxine—hypothyroidism	0.00329	0.00746	CcSEcCtD
Maprotiline—Nervousness—Levothyroxine—hypothyroidism	0.00326	0.00739	CcSEcCtD
Maprotiline—Nervousness—Dextrothyroxine—hypothyroidism	0.00326	0.00739	CcSEcCtD
Maprotiline—Weight decreased—Liotrix—hypothyroidism	0.0032	0.00726	CcSEcCtD
Maprotiline—Tremor—Dextrothyroxine—hypothyroidism	0.00314	0.00713	CcSEcCtD
Maprotiline—Tremor—Levothyroxine—hypothyroidism	0.00314	0.00713	CcSEcCtD
Maprotiline—Acute coronary syndrome—Liotrix—hypothyroidism	0.00311	0.00706	CcSEcCtD
Maprotiline—CHRM2—heart—hypothyroidism	0.0031	0.0217	CbGeAlD
Maprotiline—Myocardial infarction—Liotrix—hypothyroidism	0.0031	0.00702	CcSEcCtD
Maprotiline—Agitation—Dextrothyroxine—hypothyroidism	0.00308	0.00699	CcSEcCtD
Maprotiline—Agitation—Levothyroxine—hypothyroidism	0.00308	0.00699	CcSEcCtD
Maprotiline—Palpitations—Dextrothyroxine—hypothyroidism	0.00297	0.00672	CcSEcCtD
Maprotiline—Palpitations—Levothyroxine—hypothyroidism	0.00297	0.00672	CcSEcCtD
Maprotiline—CHRM2—cardiovascular system—hypothyroidism	0.00293	0.0204	CbGeAlD
Maprotiline—Convulsion—Dextrothyroxine—hypothyroidism	0.00291	0.00659	CcSEcCtD
Maprotiline—Convulsion—Levothyroxine—hypothyroidism	0.00291	0.00659	CcSEcCtD
Maprotiline—Anxiety—Dextrothyroxine—hypothyroidism	0.00285	0.00645	CcSEcCtD
Maprotiline—Anxiety—Levothyroxine—hypothyroidism	0.00285	0.00645	CcSEcCtD
Maprotiline—Hypoaesthesia—Liotrix—hypothyroidism	0.00282	0.0064	CcSEcCtD
Maprotiline—Confusional state—Dextrothyroxine—hypothyroidism	0.00276	0.00626	CcSEcCtD
Maprotiline—Confusional state—Levothyroxine—hypothyroidism	0.00276	0.00626	CcSEcCtD
Maprotiline—Shock—Levothyroxine—hypothyroidism	0.00269	0.00611	CcSEcCtD
Maprotiline—Shock—Dextrothyroxine—hypothyroidism	0.00269	0.00611	CcSEcCtD
Maprotiline—Tachycardia—Dextrothyroxine—hypothyroidism	0.00267	0.00606	CcSEcCtD
Maprotiline—Tachycardia—Levothyroxine—hypothyroidism	0.00267	0.00606	CcSEcCtD
Maprotiline—CHRM1—cardiovascular system—hypothyroidism	0.00266	0.0186	CbGeAlD
Maprotiline—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00265	0.006	CcSEcCtD
Maprotiline—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00265	0.006	CcSEcCtD
Maprotiline—Flushing—Liotrix—hypothyroidism	0.00263	0.00597	CcSEcCtD
Maprotiline—Arrhythmia—Liotrix—hypothyroidism	0.00253	0.00574	CcSEcCtD
Maprotiline—Alopecia—Liotrix—hypothyroidism	0.00251	0.00568	CcSEcCtD
Maprotiline—ORM1—blood—hypothyroidism	0.00248	0.0173	CbGeAlD
Maprotiline—Insomnia—Levothyroxine—hypothyroidism	0.00248	0.00561	CcSEcCtD
Maprotiline—Insomnia—Dextrothyroxine—hypothyroidism	0.00248	0.00561	CcSEcCtD
Maprotiline—Tension—Liotrix—hypothyroidism	0.00242	0.00549	CcSEcCtD
Maprotiline—Dysgeusia—Liotrix—hypothyroidism	0.00242	0.00548	CcSEcCtD
Maprotiline—HTR7—heart—hypothyroidism	0.00241	0.0168	CbGeAlD
Maprotiline—Nervousness—Liotrix—hypothyroidism	0.0024	0.00543	CcSEcCtD
Maprotiline—Fatigue—Dextrothyroxine—hypothyroidism	0.00236	0.00535	CcSEcCtD
Maprotiline—Fatigue—Levothyroxine—hypothyroidism	0.00236	0.00535	CcSEcCtD
Maprotiline—Vision blurred—Liotrix—hypothyroidism	0.00233	0.00527	CcSEcCtD
Maprotiline—Tremor—Liotrix—hypothyroidism	0.00231	0.00524	CcSEcCtD
Maprotiline—HTR7—cardiovascular system—hypothyroidism	0.00227	0.0159	CbGeAlD
Maprotiline—Agitation—Liotrix—hypothyroidism	0.00227	0.00514	CcSEcCtD
Maprotiline—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00226	0.00512	CcSEcCtD
Maprotiline—Feeling abnormal—Levothyroxine—hypothyroidism	0.00226	0.00512	CcSEcCtD
Maprotiline—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00224	0.00508	CcSEcCtD
Maprotiline—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00224	0.00508	CcSEcCtD
Maprotiline—Syncope—Liotrix—hypothyroidism	0.00221	0.00502	CcSEcCtD
Maprotiline—Palpitations—Liotrix—hypothyroidism	0.00218	0.00494	CcSEcCtD
Maprotiline—Urticaria—Dextrothyroxine—hypothyroidism	0.00218	0.00493	CcSEcCtD
Maprotiline—Urticaria—Levothyroxine—hypothyroidism	0.00218	0.00493	CcSEcCtD
Maprotiline—Loss of consciousness—Liotrix—hypothyroidism	0.00217	0.00492	CcSEcCtD
Maprotiline—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00216	0.00491	CcSEcCtD
Maprotiline—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00216	0.00491	CcSEcCtD
Maprotiline—Body temperature increased—Levothyroxine—hypothyroidism	0.00216	0.00491	CcSEcCtD
Maprotiline—Abdominal pain—Levothyroxine—hypothyroidism	0.00216	0.00491	CcSEcCtD
Maprotiline—Convulsion—Liotrix—hypothyroidism	0.00214	0.00485	CcSEcCtD
Maprotiline—SLC6A2—gonad—hypothyroidism	0.00214	0.0149	CbGeAlD
Maprotiline—Hypertension—Liotrix—hypothyroidism	0.00213	0.00483	CcSEcCtD
Maprotiline—Anxiety—Liotrix—hypothyroidism	0.00209	0.00475	CcSEcCtD
Maprotiline—HTR7—gonad—hypothyroidism	0.00206	0.0144	CbGeAlD
Maprotiline—Confusional state—Liotrix—hypothyroidism	0.00203	0.0046	CcSEcCtD
Maprotiline—Oedema—Liotrix—hypothyroidism	0.00201	0.00457	CcSEcCtD
Maprotiline—Infection—Liotrix—hypothyroidism	0.002	0.00454	CcSEcCtD
Maprotiline—Shock—Liotrix—hypothyroidism	0.00198	0.00449	CcSEcCtD
Maprotiline—Tachycardia—Liotrix—hypothyroidism	0.00197	0.00446	CcSEcCtD
Maprotiline—Asthenia—Levothyroxine—hypothyroidism	0.00196	0.00445	CcSEcCtD
Maprotiline—Asthenia—Dextrothyroxine—hypothyroidism	0.00196	0.00445	CcSEcCtD
Maprotiline—Hyperhidrosis—Liotrix—hypothyroidism	0.00195	0.00441	CcSEcCtD
Maprotiline—ORM1—liver—hypothyroidism	0.00194	0.0136	CbGeAlD
Maprotiline—Pruritus—Levothyroxine—hypothyroidism	0.00194	0.00439	CcSEcCtD
Maprotiline—Pruritus—Dextrothyroxine—hypothyroidism	0.00194	0.00439	CcSEcCtD
Maprotiline—SLC6A3—testis—hypothyroidism	0.00191	0.0133	CbGeAlD
Maprotiline—DRD2—pituitary gland—hypothyroidism	0.0019	0.0133	CbGeAlD
Maprotiline—Hypotension—Liotrix—hypothyroidism	0.00188	0.00427	CcSEcCtD
Maprotiline—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00187	0.00425	CcSEcCtD
Maprotiline—Diarrhoea—Levothyroxine—hypothyroidism	0.00187	0.00425	CcSEcCtD
Maprotiline—SLC6A2—adrenal gland—hypothyroidism	0.00186	0.013	CbGeAlD
Maprotiline—Insomnia—Liotrix—hypothyroidism	0.00182	0.00413	CcSEcCtD
Maprotiline—CHRM3—thyroid gland—hypothyroidism	0.00182	0.0127	CbGeAlD
Maprotiline—Paraesthesia—Liotrix—hypothyroidism	0.00181	0.0041	CcSEcCtD
Maprotiline—HTR7—adrenal gland—hypothyroidism	0.0018	0.0125	CbGeAlD
Maprotiline—HTR7—blood—hypothyroidism	0.0018	0.0125	CbGeAlD
Maprotiline—SLC6A3—cerebellum—hypothyroidism	0.00176	0.0123	CbGeAlD
Maprotiline—CHRM3—female gonad—hypothyroidism	0.00176	0.0123	CbGeAlD
Maprotiline—Vomiting—Dextrothyroxine—hypothyroidism	0.00174	0.00395	CcSEcCtD
Maprotiline—Vomiting—Levothyroxine—hypothyroidism	0.00174	0.00395	CcSEcCtD
Maprotiline—Fatigue—Liotrix—hypothyroidism	0.00174	0.00394	CcSEcCtD
Maprotiline—Rash—Levothyroxine—hypothyroidism	0.00173	0.00391	CcSEcCtD
Maprotiline—Rash—Dextrothyroxine—hypothyroidism	0.00173	0.00391	CcSEcCtD
Maprotiline—Dermatitis—Dextrothyroxine—hypothyroidism	0.00173	0.00391	CcSEcCtD
Maprotiline—Dermatitis—Levothyroxine—hypothyroidism	0.00173	0.00391	CcSEcCtD
Maprotiline—Constipation—Liotrix—hypothyroidism	0.00172	0.0039	CcSEcCtD
Maprotiline—Headache—Dextrothyroxine—hypothyroidism	0.00172	0.00389	CcSEcCtD
Maprotiline—Headache—Levothyroxine—hypothyroidism	0.00172	0.00389	CcSEcCtD
Maprotiline—Feeling abnormal—Liotrix—hypothyroidism	0.00166	0.00376	CcSEcCtD
Maprotiline—Gastrointestinal pain—Liotrix—hypothyroidism	0.00165	0.00373	CcSEcCtD
Maprotiline—Nausea—Levothyroxine—hypothyroidism	0.00163	0.00369	CcSEcCtD
Maprotiline—Nausea—Dextrothyroxine—hypothyroidism	0.00163	0.00369	CcSEcCtD
Maprotiline—Urticaria—Liotrix—hypothyroidism	0.0016	0.00363	CcSEcCtD
Maprotiline—Body temperature increased—Liotrix—hypothyroidism	0.00159	0.00361	CcSEcCtD
Maprotiline—Abdominal pain—Liotrix—hypothyroidism	0.00159	0.00361	CcSEcCtD
Maprotiline—CHRM3—testis—hypothyroidism	0.00156	0.0109	CbGeAlD
Maprotiline—SLC6A2—testis—hypothyroidism	0.00154	0.0108	CbGeAlD
Maprotiline—HTR2A—heart—hypothyroidism	0.0015	0.0105	CbGeAlD
Maprotiline—HTR7—testis—hypothyroidism	0.00148	0.0104	CbGeAlD
Maprotiline—Asthenia—Liotrix—hypothyroidism	0.00145	0.00328	CcSEcCtD
Maprotiline—CYP1A2—blood—hypothyroidism	0.00143	0.01	CbGeAlD
Maprotiline—Pruritus—Liotrix—hypothyroidism	0.00143	0.00323	CcSEcCtD
Maprotiline—HTR2A—cardiovascular system—hypothyroidism	0.00142	0.00989	CbGeAlD
Maprotiline—DRD2—testis—hypothyroidism	0.0014	0.0098	CbGeAlD
Maprotiline—HTR7—liver—hypothyroidism	0.0014	0.0098	CbGeAlD
Maprotiline—CYP1A2—thyroid gland—hypothyroidism	0.00138	0.00965	CbGeAlD
Maprotiline—Diarrhoea—Liotrix—hypothyroidism	0.00138	0.00312	CcSEcCtD
Maprotiline—HTR7—cerebellum—hypothyroidism	0.00137	0.00958	CbGeAlD
Maprotiline—HRH1—adrenal gland—hypothyroidism	0.00134	0.00936	CbGeAlD
Maprotiline—Dizziness—Liotrix—hypothyroidism	0.00133	0.00302	CcSEcCtD
Maprotiline—DRD2—cerebellum—hypothyroidism	0.0013	0.00905	CbGeAlD
Maprotiline—HTR2A—gonad—hypothyroidism	0.00128	0.00897	CbGeAlD
Maprotiline—Vomiting—Liotrix—hypothyroidism	0.00128	0.0029	CcSEcCtD
Maprotiline—Rash—Liotrix—hypothyroidism	0.00127	0.00288	CcSEcCtD
Maprotiline—Dermatitis—Liotrix—hypothyroidism	0.00127	0.00288	CcSEcCtD
Maprotiline—Headache—Liotrix—hypothyroidism	0.00126	0.00286	CcSEcCtD
Maprotiline—HTR2A—pituitary gland—hypothyroidism	0.00125	0.00875	CbGeAlD
Maprotiline—HRH1—female gonad—hypothyroidism	0.00125	0.00873	CbGeAlD
Maprotiline—Nausea—Liotrix—hypothyroidism	0.0012	0.00271	CcSEcCtD
Maprotiline—HTR2A—adrenal gland—hypothyroidism	0.00112	0.00782	CbGeAlD
Maprotiline—CYP1A2—liver—hypothyroidism	0.00112	0.00782	CbGeAlD
Maprotiline—HTR2A—blood—hypothyroidism	0.00112	0.00782	CbGeAlD
Maprotiline—HRH1—testis—hypothyroidism	0.00111	0.00774	CbGeAlD
Maprotiline—CYP2D6—blood—hypothyroidism	0.00102	0.00712	CbGeAlD
Maprotiline—ABCB1—adrenal cortex—hypothyroidism	0.00102	0.0071	CbGeAlD
Maprotiline—ABCB1—heart—hypothyroidism	0.000983	0.00687	CbGeAlD
Maprotiline—CYP2D6—female gonad—hypothyroidism	0.000951	0.00664	CbGeAlD
Maprotiline—ABCB1—cardiovascular system—hypothyroidism	0.000928	0.00648	CbGeAlD
Maprotiline—HTR2A—testis—hypothyroidism	0.000926	0.00647	CbGeAlD
Maprotiline—HTR2A—liver—hypothyroidism	0.000875	0.00611	CbGeAlD
Maprotiline—HTR2A—cerebellum—hypothyroidism	0.000855	0.00597	CbGeAlD
Maprotiline—CYP2D6—testis—hypothyroidism	0.000844	0.00589	CbGeAlD
Maprotiline—ABCB1—gonad—hypothyroidism	0.000842	0.00588	CbGeAlD
Maprotiline—ABCB1—pituitary gland—hypothyroidism	0.000821	0.00574	CbGeAlD
Maprotiline—CYP2D6—liver—hypothyroidism	0.000798	0.00557	CbGeAlD
Maprotiline—CYP2D6—cerebellum—hypothyroidism	0.000779	0.00544	CbGeAlD
Maprotiline—ABCB1—adrenal gland—hypothyroidism	0.000734	0.00512	CbGeAlD
Maprotiline—ABCB1—blood—hypothyroidism	0.000734	0.00512	CbGeAlD
Maprotiline—ABCB1—thyroid gland—hypothyroidism	0.000708	0.00494	CbGeAlD
Maprotiline—ABCB1—female gonad—hypothyroidism	0.000684	0.00478	CbGeAlD
Maprotiline—ABCB1—testis—hypothyroidism	0.000607	0.00424	CbGeAlD
Maprotiline—ABCB1—liver—hypothyroidism	0.000574	0.00401	CbGeAlD
Maprotiline—ABCB1—cerebellum—hypothyroidism	0.00056	0.00391	CbGeAlD
Maprotiline—CHRM3—GPCR downstream signaling—TRH—hypothyroidism	0.000102	0.00131	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—TRH—hypothyroidism	0.000101	0.0013	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—IYD—hypothyroidism	9.99e-05	0.00129	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CLTC—hypothyroidism	9.97e-05	0.00128	CbGpPWpGaD
Maprotiline—HTR7—GPCR ligand binding—POMC—hypothyroidism	9.92e-05	0.00128	CbGpPWpGaD
Maprotiline—DRD2—GPCR ligand binding—AVP—hypothyroidism	9.71e-05	0.00125	CbGpPWpGaD
Maprotiline—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	9.6e-05	0.00124	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—TSHB—hypothyroidism	9.58e-05	0.00123	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—TSHR—hypothyroidism	9.58e-05	0.00123	CbGpPWpGaD
Maprotiline—HTR2A—GPCR ligand binding—AVP—hypothyroidism	9.55e-05	0.00123	CbGpPWpGaD
Maprotiline—HRH1—GPCR ligand binding—AVP—hypothyroidism	9.53e-05	0.00123	CbGpPWpGaD
Maprotiline—CHRM1—GPCR ligand binding—AVP—hypothyroidism	9.5e-05	0.00122	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—TRH—hypothyroidism	9.49e-05	0.00122	CbGpPWpGaD
Maprotiline—CHRM3—GPCR ligand binding—AVP—hypothyroidism	9.47e-05	0.00122	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—IYD—hypothyroidism	9.41e-05	0.00121	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CLTC—hypothyroidism	9.41e-05	0.00121	CbGpPWpGaD
Maprotiline—CHRM2—GPCR ligand binding—AVP—hypothyroidism	9.38e-05	0.00121	CbGpPWpGaD
Maprotiline—CHRM4—GPCR ligand binding—POMC—hypothyroidism	9.37e-05	0.00121	CbGpPWpGaD
Maprotiline—SLC6A3—Transmembrane transport of small molecules—AVP—hypothyroidism	9.36e-05	0.0012	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—TRH—hypothyroidism	9.33e-05	0.0012	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—TRH—hypothyroidism	9.31e-05	0.0012	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—TSHB—hypothyroidism	9.31e-05	0.0012	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—TSHR—hypothyroidism	9.31e-05	0.0012	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—TRH—hypothyroidism	9.28e-05	0.00119	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—TRH—hypothyroidism	9.25e-05	0.00119	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—TRH—hypothyroidism	9.16e-05	0.00118	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—TSHB—hypothyroidism	9.16e-05	0.00118	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—TSHR—hypothyroidism	9.16e-05	0.00118	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—TSHB—hypothyroidism	9.14e-05	0.00118	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—TSHR—hypothyroidism	9.14e-05	0.00118	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—TSHB—hypothyroidism	9.11e-05	0.00117	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—TSHR—hypothyroidism	9.11e-05	0.00117	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—TSHB—hypothyroidism	9.08e-05	0.00117	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—TSHR—hypothyroidism	9.08e-05	0.00117	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CLTC—hypothyroidism	9.01e-05	0.00116	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—TSHB—hypothyroidism	9e-05	0.00116	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—TSHR—hypothyroidism	9e-05	0.00116	CbGpPWpGaD
Maprotiline—CHRM5—GPCR ligand binding—POMC—hypothyroidism	8.97e-05	0.00115	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—VAV3—hypothyroidism	8.75e-05	0.00113	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TRH—hypothyroidism	8.61e-05	0.00111	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—ATP5O—hypothyroidism	8.49e-05	0.00109	CbGpPWpGaD
Maprotiline—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	8.47e-05	0.00109	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—TSHR—hypothyroidism	8.46e-05	0.00109	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—TSHB—hypothyroidism	8.46e-05	0.00109	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—AVP—hypothyroidism	8.43e-05	0.00109	CbGpPWpGaD
Maprotiline—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	8.34e-05	0.00107	CbGpPWpGaD
Maprotiline—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	8.32e-05	0.00107	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—TSHB—hypothyroidism	8.32e-05	0.00107	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—TSHR—hypothyroidism	8.32e-05	0.00107	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—TSHB—hypothyroidism	8.3e-05	0.00107	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—TSHR—hypothyroidism	8.3e-05	0.00107	CbGpPWpGaD
Maprotiline—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	8.29e-05	0.00107	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—TSHR—hypothyroidism	8.28e-05	0.00106	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—TSHB—hypothyroidism	8.28e-05	0.00106	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—VAV3—hypothyroidism	8.27e-05	0.00106	CbGpPWpGaD
Maprotiline—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	8.27e-05	0.00106	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—TSHB—hypothyroidism	8.25e-05	0.00106	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—TSHR—hypothyroidism	8.25e-05	0.00106	CbGpPWpGaD
Maprotiline—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	8.19e-05	0.00105	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—TSHR—hypothyroidism	8.17e-05	0.00105	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—TSHB—hypothyroidism	8.17e-05	0.00105	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TRH—hypothyroidism	8.13e-05	0.00105	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ATP5O—hypothyroidism	8.01e-05	0.00103	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—TPO—hypothyroidism	7.99e-05	0.00103	CbGpPWpGaD
Maprotiline—CYP2D6—Biological oxidations—POMC—hypothyroidism	7.98e-05	0.00103	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—IYD—hypothyroidism	7.98e-05	0.00103	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—AVP—hypothyroidism	7.96e-05	0.00103	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—VAV3—hypothyroidism	7.95e-05	0.00102	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—VAV3—hypothyroidism	7.92e-05	0.00102	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TRH—hypothyroidism	7.79e-05	0.001	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TSHB—hypothyroidism	7.68e-05	0.000988	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TSHR—hypothyroidism	7.68e-05	0.000988	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—AVP—hypothyroidism	7.66e-05	0.000986	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—AVP—hypothyroidism	7.63e-05	0.000982	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—TPO—hypothyroidism	7.53e-05	0.000969	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—VAV3—hypothyroidism	7.51e-05	0.000966	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	7.49e-05	0.000964	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CLTC—hypothyroidism	7.35e-05	0.000946	CbGpPWpGaD
Maprotiline—HTR2C—GPCR ligand binding—POMC—hypothyroidism	7.31e-05	0.000941	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TSHB—hypothyroidism	7.25e-05	0.000933	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TSHR—hypothyroidism	7.25e-05	0.000933	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—AVP—hypothyroidism	7.23e-05	0.000931	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—VAV3—hypothyroidism	7.19e-05	0.000925	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TSHB—hypothyroidism	6.94e-05	0.000894	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TSHR—hypothyroidism	6.94e-05	0.000894	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—AVP—hypothyroidism	6.93e-05	0.000891	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—SH2B3—hypothyroidism	6.84e-05	0.000881	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ATP5O—hypothyroidism	6.78e-05	0.000873	CbGpPWpGaD
Maprotiline—CYP1A2—Biological oxidations—POMC—hypothyroidism	6.76e-05	0.00087	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CLTC—hypothyroidism	6.48e-05	0.000834	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—SH2B3—hypothyroidism	6.46e-05	0.000832	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—VAV3—hypothyroidism	6.45e-05	0.000831	CbGpPWpGaD
Maprotiline—DRD2—GPCR ligand binding—POMC—hypothyroidism	6.45e-05	0.00083	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CLTC—hypothyroidism	6.38e-05	0.000821	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—TPO—hypothyroidism	6.38e-05	0.000821	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CLTC—hypothyroidism	6.37e-05	0.000819	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TRH—hypothyroidism	6.35e-05	0.000817	CbGpPWpGaD
Maprotiline—HTR2A—GPCR ligand binding—POMC—hypothyroidism	6.35e-05	0.000817	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CLTC—hypothyroidism	6.35e-05	0.000817	CbGpPWpGaD
Maprotiline—HRH1—GPCR ligand binding—POMC—hypothyroidism	6.34e-05	0.000815	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CLTC—hypothyroidism	6.33e-05	0.000814	CbGpPWpGaD
Maprotiline—CHRM1—GPCR ligand binding—POMC—hypothyroidism	6.32e-05	0.000813	CbGpPWpGaD
Maprotiline—CHRM3—GPCR ligand binding—POMC—hypothyroidism	6.3e-05	0.00081	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CLTC—hypothyroidism	6.26e-05	0.000806	CbGpPWpGaD
Maprotiline—CHRM2—GPCR ligand binding—POMC—hypothyroidism	6.23e-05	0.000802	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—AVP—hypothyroidism	6.22e-05	0.0008	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—SH2B3—hypothyroidism	6.19e-05	0.000796	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.91e-05	0.000761	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	5.91e-05	0.00076	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—VAV3—hypothyroidism	5.86e-05	0.000754	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—TSHB—hypothyroidism	5.83e-05	0.00075	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—VAV3—hypothyroidism	5.7e-05	0.000733	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TSHB—hypothyroidism	5.66e-05	0.000728	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TSHR—hypothyroidism	5.66e-05	0.000728	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—AVP—hypothyroidism	5.65e-05	0.000727	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—POMC—hypothyroidism	5.6e-05	0.000721	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—VAV3—hypothyroidism	5.6e-05	0.000721	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TRH—hypothyroidism	5.6e-05	0.000721	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—VAV3—hypothyroidism	5.59e-05	0.00072	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—VAV3—hypothyroidism	5.57e-05	0.000717	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—VAV3—hypothyroidism	5.56e-05	0.000715	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TRH—hypothyroidism	5.51e-05	0.00071	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—VAV3—hypothyroidism	5.5e-05	0.000708	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TRH—hypothyroidism	5.5e-05	0.000708	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—AVP—hypothyroidism	5.49e-05	0.000706	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TRH—hypothyroidism	5.48e-05	0.000706	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TRH—hypothyroidism	5.47e-05	0.000704	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TRH—hypothyroidism	5.41e-05	0.000697	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—AVP—hypothyroidism	5.4e-05	0.000695	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—AVP—hypothyroidism	5.39e-05	0.000693	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—AVP—hypothyroidism	5.37e-05	0.000691	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—AVP—hypothyroidism	5.35e-05	0.000689	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—AVP—hypothyroidism	5.3e-05	0.000682	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—POMC—hypothyroidism	5.29e-05	0.000681	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PIK3C2A—hypothyroidism	5.19e-05	0.000668	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—VAV3—hypothyroidism	5.17e-05	0.000666	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—POMC—hypothyroidism	5.09e-05	0.000655	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—VAV3—hypothyroidism	5.09e-05	0.000655	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—VAV3—hypothyroidism	5.08e-05	0.000654	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—PRL—hypothyroidism	5.08e-05	0.000653	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—POMC—hypothyroidism	5.07e-05	0.000652	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—VAV3—hypothyroidism	5.06e-05	0.000651	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—VAV3—hypothyroidism	5.05e-05	0.000649	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—SH2B3—hypothyroidism	5.04e-05	0.000649	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—VAV3—hypothyroidism	5e-05	0.000643	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TSHB—hypothyroidism	4.99e-05	0.000643	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TSHR—hypothyroidism	4.99e-05	0.000643	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—AVP—hypothyroidism	4.98e-05	0.000641	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TSHB—hypothyroidism	4.91e-05	0.000633	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TSHR—hypothyroidism	4.91e-05	0.000633	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TSHB—hypothyroidism	4.9e-05	0.000631	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TSHR—hypothyroidism	4.9e-05	0.000631	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—AVP—hypothyroidism	4.9e-05	0.000631	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—AVP—hypothyroidism	4.89e-05	0.00063	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TSHB—hypothyroidism	4.89e-05	0.000629	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TSHR—hypothyroidism	4.89e-05	0.000629	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—AVP—hypothyroidism	4.88e-05	0.000628	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TSHB—hypothyroidism	4.87e-05	0.000627	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TSHR—hypothyroidism	4.87e-05	0.000627	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—AVP—hypothyroidism	4.86e-05	0.000626	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TSHB—hypothyroidism	4.83e-05	0.000621	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TSHR—hypothyroidism	4.83e-05	0.000621	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—AVP—hypothyroidism	4.81e-05	0.00062	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—POMC—hypothyroidism	4.81e-05	0.000619	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—PRL—hypothyroidism	4.79e-05	0.000617	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—VAV3—hypothyroidism	4.7e-05	0.000604	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	4.65e-05	0.000599	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—POMC—hypothyroidism	4.6e-05	0.000592	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—PRL—hypothyroidism	4.59e-05	0.000591	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—AVP—hypothyroidism	4.52e-05	0.000582	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—SH2B3—hypothyroidism	4.45e-05	0.000573	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—VAV3—hypothyroidism	4.43e-05	0.000571	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—SH2B3—hypothyroidism	4.38e-05	0.000564	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—SH2B3—hypothyroidism	4.37e-05	0.000563	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—SLC5A5—hypothyroidism	4.36e-05	0.000561	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—SH2B3—hypothyroidism	4.36e-05	0.000561	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—SH2B3—hypothyroidism	4.34e-05	0.000559	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—SH2B3—hypothyroidism	4.3e-05	0.000554	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—AVP—hypothyroidism	4.27e-05	0.00055	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—VAV3—hypothyroidism	4.25e-05	0.000547	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—POMC—hypothyroidism	4.13e-05	0.000532	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—AVP—hypothyroidism	4.09e-05	0.000527	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—POMC—hypothyroidism	3.75e-05	0.000483	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—PRL—hypothyroidism	3.74e-05	0.000482	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—TSHB—hypothyroidism	3.7e-05	0.000476	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—POMC—hypothyroidism	3.65e-05	0.000469	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—POMC—hypothyroidism	3.59e-05	0.000462	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—POMC—hypothyroidism	3.58e-05	0.000461	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—POMC—hypothyroidism	3.57e-05	0.000459	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—POMC—hypothyroidism	3.56e-05	0.000458	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—POMC—hypothyroidism	3.52e-05	0.000453	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—TSHB—hypothyroidism	3.48e-05	0.000448	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—VAV3—hypothyroidism	3.46e-05	0.000446	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—AVP—hypothyroidism	3.34e-05	0.000429	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—POMC—hypothyroidism	3.31e-05	0.000426	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PRL—hypothyroidism	3.3e-05	0.000425	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PIK3C2A—hypothyroidism	3.3e-05	0.000424	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—POMC—hypothyroidism	3.26e-05	0.000419	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—POMC—hypothyroidism	3.25e-05	0.000418	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PRL—hypothyroidism	3.25e-05	0.000418	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PRL—hypothyroidism	3.24e-05	0.000417	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—POMC—hypothyroidism	3.24e-05	0.000417	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PRL—hypothyroidism	3.23e-05	0.000416	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—POMC—hypothyroidism	3.23e-05	0.000416	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PRL—hypothyroidism	3.22e-05	0.000415	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—POMC—hypothyroidism	3.2e-05	0.000412	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PRL—hypothyroidism	3.19e-05	0.000411	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	3.11e-05	0.0004	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—VAV3—hypothyroidism	3.06e-05	0.000393	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—POMC—hypothyroidism	3.01e-05	0.000387	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—VAV3—hypothyroidism	3.01e-05	0.000387	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—VAV3—hypothyroidism	3e-05	0.000386	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—VAV3—hypothyroidism	2.99e-05	0.000385	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—VAV3—hypothyroidism	2.98e-05	0.000384	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—VAV3—hypothyroidism	2.95e-05	0.00038	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—TSHB—hypothyroidism	2.95e-05	0.00038	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—AVP—hypothyroidism	2.94e-05	0.000379	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—AVP—hypothyroidism	2.9e-05	0.000373	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IGF1—hypothyroidism	2.89e-05	0.000372	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—AVP—hypothyroidism	2.89e-05	0.000372	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—AVP—hypothyroidism	2.88e-05	0.000371	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—AVP—hypothyroidism	2.87e-05	0.00037	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—AVP—hypothyroidism	2.84e-05	0.000366	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—POMC—hypothyroidism	2.84e-05	0.000365	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—SLC5A5—hypothyroidism	2.77e-05	0.000356	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IGF1—hypothyroidism	2.73e-05	0.000352	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—POMC—hypothyroidism	2.72e-05	0.00035	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	2.63e-05	0.000339	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IGF1—hypothyroidism	2.62e-05	0.000337	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—SLC5A5—hypothyroidism	2.61e-05	0.000336	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.6e-05	0.000334	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—POMC—hypothyroidism	2.28e-05	0.000294	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—POMC—hypothyroidism	2.22e-05	0.000285	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—SLC5A5—hypothyroidism	2.21e-05	0.000284	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IGF1—hypothyroidism	2.13e-05	0.000274	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—POMC—hypothyroidism	1.96e-05	0.000252	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—POMC—hypothyroidism	1.92e-05	0.000248	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—POMC—hypothyroidism	1.92e-05	0.000247	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—POMC—hypothyroidism	1.91e-05	0.000246	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—POMC—hypothyroidism	1.91e-05	0.000246	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—POMC—hypothyroidism	1.89e-05	0.000243	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IGF1—hypothyroidism	1.88e-05	0.000242	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IGF1—hypothyroidism	1.85e-05	0.000238	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IGF1—hypothyroidism	1.85e-05	0.000238	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IGF1—hypothyroidism	1.84e-05	0.000237	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IGF1—hypothyroidism	1.84e-05	0.000236	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IGF1—hypothyroidism	1.82e-05	0.000234	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—POMC—hypothyroidism	1.45e-05	0.000186	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—POMC—hypothyroidism	1.36e-05	0.000176	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—POMC—hypothyroidism	1.16e-05	0.000149	CbGpPWpGaD
